Last week, we looked at what was said about Medicare Part D costs and beneficiary premiums when the program was created – and at what has actually happened in the first 10 years of the program.
This week, we’re looking at what was said about competition in Part D then and now.
Learn more about how successful competition works in Part D here, and tune in next week for our final Part D Then and Now.
Allyson Funk Ally is a former senior director of public affairs at PhRMA focused on advocacy issues for the biopharmaceutical industry. Her expertise includes Medicare, Medicaid, 340B, health reform and more. Prior to PhRMA, her experience included leading health communications for a large membership organization, supporting public affairs clients and working for the governor of Louisiana.
Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
"1. Information Collection."